Cargando…

Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiwari, Vishvanath, Roy, Ranita, Tiwari, Monalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471432/ https://www.ncbi.nlm.nih.gov/pubmed/26150810 http://dx.doi.org/10.3389/fmicb.2015.00618

Ejemplares similares

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Molecular mechanism of antimicrobial activity of chlorhexidine against carbapenem-resistant Acinetobacter baumannii
por: Biswas, Deepika, et al.
Publicado: (2019)

Mechanism of Anti-bacterial Activity of Zinc Oxide Nanoparticle Against Carbapenem-Resistant Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2018)

Design of novel hybrid secondary metabolite targets to diguanylate cyclase of Acinetobacter baumannii
por: Tiwari, Monalisa, et al.
Publicado: (2021)

Assessment of Molecular Mechanism of Gallate-Polyvinylpyrrolidone-Capped Hybrid Silver Nanoparticles against Carbapenem-Resistant Acinetobacter baumannii
por: Tiwari, Monalisa, et al.
Publicado: (2020)

Assessment of potassium ion channel during electric signalling in biofilm formation of Acinetobacter baumannii for finding antibiofilm molecule
por: Tiwari, Monalisa, et al.
Publicado: (2023)

Polyvinylpyrrolidone-Capped Silver Nanoparticle Inhibits Infection of Carbapenem-Resistant Strain of Acinetobacter baumannii in the Human Pulmonary Epithelial Cell
por: Tiwari, Vishvanath, et al.
Publicado: (2017)

Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
por: Roy, Ranita, et al.
Publicado: (2017)

Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii
por: Solanki, Vandana, et al.
Publicado: (2018)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
por: Vashist, Jitendra, et al.
Publicado: (2011)

Comparative Proteomics of Inner Membrane Fraction from Carbapenem-Resistant Acinetobacter baumannii with a Reference Strain
por: Tiwari, Vishvanath, et al.
Publicado: (2012)

In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds
por: Denysko, Tetyana Valeriyivna, et al.
Publicado: (2022)

Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division
por: Chai, Wern Chern, et al.
Publicado: (2022)

Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates
por: Breine, Anke, et al.
Publicado: (2022)

Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter baumannii and Other Bacteria
por: McNeilly, Oliver, et al.
Publicado: (2021)

Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa
por: Solanki, Vandana, et al.
Publicado: (2019)

Virulent Epidemic Pneumonia in Sheep Caused by the Human Pathogen Acinetobacter baumannii
por: Linz, Bodo, et al.
Publicado: (2018)

Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125
por: Chatterjee, Somdatta, et al.
Publicado: (2016)

Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Acinetobacter baumannii
por: Raorane, Chaitany Jayprakash, et al.
Publicado: (2019)

Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection
por: Qu, Junyan, et al.
Publicado: (2020)

Acinetobacter baumannii: An emerging opportunistic pathogen
por: Howard, Aoife, et al.
Publicado: (2012)

Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii
por: Miyasaki, Yoko, et al.
Publicado: (2013)

The Mechanisms of Disease Caused by Acinetobacter baumannii
por: Morris, Faye C., et al.
Publicado: (2019)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Structure and Evolution of Acinetobacter baumannii Plasmids
por: Salgado-Camargo, Abraham D., et al.
Publicado: (2020)

The higBA Toxin-Antitoxin Module From the Opportunistic Pathogen Acinetobacter baumannii – Regulation, Activity, and Evolution
por: Armalytė, Julija, et al.
Publicado: (2018)

Bactericidal activity of herbal volatile oil extracts against multidrug-resistant Acinetobacter baumannii
por: Intorasoot, Amornrat, et al.
Publicado: (2017)

Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumannii
por: Wozniak, Agata, et al.
Publicado: (2019)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
por: Zhang, Hui, et al.
Publicado: (2021)

Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa
por: Yang, Hang, et al.
Publicado: (2015)

Small, Enigmatic Plasmids of the Nosocomial Pathogen, Acinetobacter baumannii: Good, Bad, Who Knows?
por: Lean, Soo Sum, et al.
Publicado: (2017)

The abaI/abaR Quorum Sensing System Effects on Pathogenicity in Acinetobacter baumannii
por: Sun, Xiaoyu, et al.
Publicado: (2021)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii
por: Prieto Martin Gil, Sonia, et al.
Publicado: (2021)

Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii
por: Islam, Md Maidul, et al.
Publicado: (2022)

Antimicrobial peptide 2K4L disrupts the membrane of multidrug-resistant Acinetobacter baumannii and protects mice against sepsis
por: Ji, Fangyu, et al.
Publicado: (2023)

Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii
por: Chen, Xi, et al.
Publicado: (2022)

In vitro and in vivo synergistic effect of chrysin in combination with colistin against Acinetobacter baumannii
por: Zhao, Yining, et al.
Publicado: (2022)

Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation
por: Lin, Ming-Feng, et al.
Publicado: (2020)

Antimicrobial Peptide Cec4 Eradicates the Bacteria of Clinical Carbapenem-Resistant Acinetobacter baumannii Biofilm
por: Liu, Weiwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_muvn8b3d657e0g0f9fo6s10hn3